Please login to the form below

Not currently logged in
Email:
Password:

Kala Pharma appoints Fovea founder Bernard Gilly to board

He previously formed the company that became Sanofi’s ophthalmology business

Dr Bernard Gilly, founder and CEO of Sanofi-owned Fovea, has joined the board of Kala Pharmaceuticals.

He brings years of experience in eye treatment to Kala, which is developing mucosal penetrating products in a number of ophthalmic diseases.

“Dr Gilly is a seasoned entrepreneur in the biotechnology industry having spent over 20 years building and investing in leading life science companies,” said Dr Guillaume Pfefer, Kala's president and CEO.

“His track record and expertise in the ophthalmology space is an invaluable addition to Kala as we advance our pipeline of transformative ophthalmic products into the clinic.”

Dr Gilly, along with Professor Jose Sahel and Pierre Belichard, set up Fovea in 2005. The company was acquired by Sanofi in 2009, becoming the French pharma firm's ophthalmology division.

Prior to his involvement with Fovea, Dr Gilly was a venture partner with Sofinnova Partners from 2000 to 2005.

He also served as a co-president and VP of R&D of Sanofi Pasteur and VP of R&D of BioMérieux.

His other entrepreneurial efforts include helping to found several biotech companies, including Domain Therapeutics, WebSurg, Kutexis, GenSight Biologicals, Pixium Vision and Enterome. He currently serves as chair at the latter three companies.

29th November 2012

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics